Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Clara Alsius Rance

Clara Alsius Rance

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Montserrat Mohedano Fret

Montserrat Mohedano Fret

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Marina Serena Calderon

Marina Serena Calderon

Gestió i Administració
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more
Maria del Carmen Llorente Olmedo

Maria del Carmen Llorente Olmedo

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.